Skip to main content
Eli Lilly and Company (ETR:LLY)
Germany flag Germany · Delayed Price · Currency is EUR
670.70
-8.60 (-1.27%)
Jun 27, 2025, 5:35 PM CET

Eli Lilly and Company Revenue

Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.

Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.50
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
611.86B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.32B
Bayer Aktiengesellschaft 46.58B
Fresenius SE & Co. KGaA 22.13B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.17B
Fielmann Group AG 2.33B
Revenue Rankings

Eli Lilly and Company News

More News